Robotic and laparoscopic pelvic lymph node dissection for rectal cancer: short-term outcomes of 21 consecutive series

Bae, Sung Uk; Saklani, Avanish; Hur, Hyuk; Min, Byung Soh; Baik, Seung Hyuk; Lee, Kang Young; Kim, Nam Kyu

doi:10.4174/astr.2014.86.2.76

Cited by 44 publications

(26 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Initial small series have confirmed the feasibility of robotic lateral pelvic lymph node dissection [66,67] . In our institute, we standardized the technique of robotic lateral pelvic lymph node dissection [57] .…”

Section: Lateral Pelvic Lymph Node Dissectionmentioning

confidence: 99%

Minimal invasive approach for beyond total mesorectal excision/extended resections in rectal cancer

Kumar¹,

Kammar²,

Saklani³

2018

MIS

View full text Add to dashboard Cite

Minimal invasive surgery (MIS) is an accepted modality of treatment for rectal cancer. The indications for MIS have gradually been extended to locally advanced and locally recurrent rectal cancer as a result of technological advances in instrumentation, advances in surgical techniques, increased surgeon experience, and high volume center. However, safety and feasibility of laparoscopic surgery and robotic surgery in beyond total mesorectal excision (b-TME) and extended TME (e-TME) are not well established. This review summarizes the current evidence for MIS approach for b-TME/extended resections in rectal cancer. A systematic search was carried out in PubMed. Studies available in English related to MIS approach in b-TME/e-TME in rectal cancers were identified and evaluated. This review concludes MIS is feasible with good perioperative outcomes in b-TME/e-TME in carefully selected patients. Laparoscopic surgery has considerable learning curve and should be performed by experienced surgical teams. Robotic surgery is feasible and beneficial in complex resection in pelvis. However, evidence for long-term oncological outcomes of MIS in b-TME/e-TME is low and needs to be studied further by randomized controlled trial once enough numbers are possible in institutes with high volume rate.

show abstract

Section: Lateral Pelvic Lymph Node Dissectionmentioning

confidence: 99%

Minimal invasive approach for beyond total mesorectal excision/extended resections in rectal cancer

Kumar¹,

Kammar²,

Saklani³

2018

MIS

View full text Add to dashboard Cite

show abstract

“…For patients selected for LPND, there are several surgical approaches, including open, laparoscopic or robotic techniques. In the literature, there are several reports of successful robotic LPDN and TME resection following nCRT with minimal conversions and complications . This new technology provides an excellent alternative to open or laparoscopic methods, as it not only it provides an excellent field of view with constant retraction, but it also offers good manoeuvrability in the narrowed, confined space of the pelvis.…”

Section: Discussionmentioning

confidence: 99%

Lateral pelvic lymph node dissection for low rectal cancers: A review on current practice

2016

View full text Add to dashboard Cite

The management of rectal cancer with lateral lymph node involvement is distinctly different between Japan and Western countries. In Japan, total mesorectal excision (TME) surgery followed by autonomic nervepreserving lateral pelvic lymph node dissection (LPND) is the standard surgical treatment, whereas in Western countries, patients are subjected to neoadjuvant cheomoradiotherapy followed by TME surgery. The present study aims to explore the current practice and role of LPND in rectal cancer.

show abstract

“…Conversely, lateral pelvic lymph node dissection with robotic surgery using multi-articulated flexible devices appears to decrease surgeon stress (Fig. 4), with the efficacy of this approach being reported by several advanced institutions [49,50].…”

Section: Lateral Pelvic Lymph Node Dissectionmentioning

confidence: 97%

Recent advances in robotic surgery for rectal cancer

et al. 2015

View full text Add to dashboard Cite

Robotic technology, which has recently been introduced to the field of surgery, is expected to be useful, particularly in treating rectal cancer where precise manipulation is necessary in the confined pelvic cavity. Robotic surgery overcomes the technical drawbacks inherent to laparoscopic surgery for rectal cancer through the use of multi-articulated flexible tools, three-dimensional stable camera platforms, tremor filtering and motion scaling functions, and greater ergonomic and intuitive device manipulation. Assessments of the feasibility and safety of robotic surgery for rectal cancer have reported similar operation times, blood loss during surgery, rates of postoperative morbidity, and circumferential resection margin involvement when compared with laparoscopic surgery. Furthermore, rates of conversion to open surgery are reportedly lower with increased urinary and male sexual functions in the early postoperative period compared with laparoscopic surgery, demonstrating the technical advantages of robotic surgery for rectal cancer. However, long-term outcomes and the cost-effectiveness of robotic surgery for rectal cancer have not been fully evaluated yet; therefore, large-scale clinical studies are required to evaluate the efficacy of this new technology.

show abstract

Robotic and laparoscopic pelvic lymph node dissection for rectal cancer: short-term outcomes of 21 consecutive series

Cited by 44 publications

References 22 publications

Minimal invasive approach for beyond total mesorectal excision/extended resections in rectal cancer

Minimal invasive approach for beyond total mesorectal excision/extended resections in rectal cancer

Lateral pelvic lymph node dissection for low rectal cancers: A review on current practice

Recent advances in robotic surgery for rectal cancer

Contact Info

Product

Resources

About